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and reperfusion, DRP treatment signiﬁcantly increased ejection frac-
tion in this study (DRP group: 40.17.2%; Control group: 27.89.1%;
Sham group: 53.77.6%; P<0.01). Our results showed that DRP
decreased LVEDP and increased LVSP in DRP group compared
with the control group (LVEDP: DRP group 13.468.54 mmHg vs.
Control group 26.2313.12 mmHg vs. Sham group 4.835.42 mmHg,
P<0.01; LVSP: DRP group 87.7112.68 mmHg vs. Control group
69.9011.08 mmHg vs. Sham group 113.2416.76 mmHg, P<0.05).
Myocardial infarct size was signiﬁcantly decreased in DRP group
compared with that in the control group (DRP group: 22.038.67%;
Control group: 29.5411.36%; Sham group: 0.000.00%; P<0.01).
CONCLUSIONS These results suggested that DRPs had a protective
effect on cardiac I/R injury of rat hearts and it may offer a
new potential approach for the treatment of acute ischemic heart
diseases.
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Protective effects of naringin on diabetic cardiomyopathy in rats through
inhibiting p38MAPK pathway
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OBJECTIVES To explore the roles of p38MAPK in diabetic cardiomy-
opathy. To investigate wheather Naringin protects cardiomyocytes
against diabetic cardiomyopathy through inhibiting p38MAPK
pathway.
METHODS The 60 male SD rats were randomly divided into normal
control group (10 rats), model group (50 rats). Diabetic rats induced by
high-sugar and high fat diet and intraperitoneal injection of strepto-
zotocin. Naringin (20/40/80 mg$kg-1$d-1) and SB203580 were
administered in diabetic rats for six weeks. Blood glucose were
detected every 2 weeks, expression of myocardial t-p38MAPK and p-
p38MAPK were tested by Western blotting Assay. Serum BNP were
assayed using ELISA kit. Morphology of myocardial cell and myocar-
dial structure were observed by light microscopy and electron
microscopy.
RESULTS Naringin could lower blood glucose, BNP and heart to
weight index in STZ-induced diabetic cardiomyopathy rat.
Morphology of myocardial cell and myocardial structure were
analyzed through light microscopy and electron microscopy, which
were improved by naringin treatment. Compared with the normal
control group, the p-p38MAPK expression of myocardial tissue in DCM
rats treated by naringin were decreased similar to the inhibitory effect
of a p38MAPK inhibitor SB203580.
CONCLUSIONS Naringin could effectively prevent myocardial
remodeling and improve cardiac function via inhibiting p38MAPK
pathway.
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OBJECTIVES Mobilization and homing of bone-marrow mesenchymal
stem cells (BMSCs) were observed in acute myocardial ischemic
injury, but disappeared in a long-term ischemic stress along with
depressed copper (Cu) concentrations in the heart. Cu is required for
hypoxia-inducible transcription factor-1 (HIF-1) regulation of expres-
sion of BMSC homing factors. The present study was to test the hy-
pothesis that Cu supplementation recovers BMSC homing signaling
system, leading to BMSC homing to the chronic ischemic infarct area
of heart.
METHODS Male adult New Zealand rabbits were subjected to coronary
artery ligation to generate myocardial ischemia. Six months after
myocardial ischemia, a newly developed ultrasound contrast micro-
bubble composed of Cu-albumin surfaced structure was used to spe-
ciﬁcally deliver Cu to the infarct area. The autologous BMSCs were
labeled with ﬂuorescence and injected via i.v. to the rabbits 24 hours
before the heart harvest. AMD3100, the speciﬁc SDF-1/CXCR4 axis
blocker, was used to treat the labeled BMSCs in one group.RESULTS BMSCs signaling was observed within 7 days after myocar-
dial ischemia and identiﬁed in the ischemic area; but six month after
myocardial ischemia, the labeled cells were not found in the ischemic
area. The ultrasound-Cu-delivering led to homing of the labeled
BMSCs to the chronic ischemic infarct area. AMD3100 blocked the
recovery of Cu-microbubble-induced homing of BMSCs.
CONCLUSIONS This study thus demonstrated that Cu supplementa-
tion reestablishes the signaling pathways for homing of BMSCs to the
chronic ischemic area, which involves the role of Cu-activated HIF-1
transcriptional activity.
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Cardiac ace2/mas expression and cardiac remodeling in hypertensive rats
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OBJECTIVES The recent discovery of the new components of the
renin-angiotensin system (RAS) suggests the importance of the
maintenance of cardiovascular structure and functions. To assess the
role of the ACE2-Mas axis in the regulation of cardiac structure and
function, the present work investigated the expression of ACE2 and
Mas receptor in the heart in the cardiac remodelling that occurs in
aortic constricted rats.
METHODS Partial abdominal aortic ligation was carried out in Spra-
gue-Dawley rats. Angiotensin AT1 receptor blockade and ACE inhibi-
tion were achieved by losartan and enalapril treatment, respectively.
RESULTS Results showed that aortic constriction increased left
ventricular hypertrophy, ﬁbrosis, MAP, plasma renin activity (PRA)
and cardiac ACE levels, but decreased the expression of cardiac
ACE2 and Mas receptor. Losartan treatment signiﬁcantly decreased
MAP, left ventricle hypertrophy (LVH), ﬁbrosis, and increased car-
diac ACE2 and Mas expression. Enalapril also improved the cardiac
parameters with a rise in cardiac ACE2, but did not change the Mas
level.
CONCLUSIONS Aortic constriction results in cardiac hypertrophy,
ﬁbrosis and a rise of cardiac ACE expression. Both AT1 receptor
blocker and ACE inhibitor play a cardioprotective role in aortic
constriction. However, AT1 receptor blocker particularly promotes
cardiac ACE2 and Mas receptor levels. ACE inhibitor is associated with
the inhibition of ACE and normalization of cardiac ACE2 activity.
ACKNOWLEDGEMENT This study was supported by the Natural
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Wuhan, China
OBJECTIVES We tested the hypothesis that low level electromagnetic
ﬁeld (EMF) could suppress intermittent hypoxia induced atrial ﬁbril-
lation (AF) through autonomic modulating.
METHODS Electrode catheters were attached to atria, and all pulmo-
nary veins. Helmholtz coils were powered by a function generator
inducing an EMF. The ventilators were adjusted to simulate the
intermittent hypoxia for 1 hour as an acute intermittent hypoxia
model. Programmed stimulation determined the effective refractory
period (ERP) and the window of vulnerability (WOV), a measure of AF
inducibility. 40 ms of high-frequency stimulation (HFS; 100 Hz, 0.01
ms pulse width) was delivered 2 ms after atrial pacing (during the
refractory period) to determine the AF threshold (AF-TH) at each site.
Other electrodes were attached to the superior left ganglionated plexi
(SLGP) and left stellate ganglion (LSG) so that HFS (20 Hz, 0.1 ms pulse
width) to these sites induced SR slowing and blood pressure (BP)
elevation, respectively. Neural activities recorded from the SLGP, LSG
and Renal sympathetic nerve (RSN).
RESULTS
(1) Intermittent hypoxia induced a increase in WOV, a decrease in
AF-TH and ERP at all sites (all P < 0.05).
(2) The SR slowing response induced by SLGP stimulation and BP
elevation induced by LSG stimulation were facilitated by 1 hour
intermittent hypoxia.
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the SLGP, LSG and RSN were markedly increased by 1 hour inter-
mittent hypoxia.
(4) EMF reversed all these changes induced by 1 hour intermittent
hypoxia.
CONCLUSIONS EMF suppressed AF inducibility and the responses to
SLGP and LSG stimulation induced by intermittent hypoxia. Inhibition
of neural activities in the GP, LSG and RSN may be a mechanism
underlying these results.
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OBJECTIVES Acehytisine (previously named Guanfu base A), a novel
diterpene alkaloid isolated from the root of aconitum coreanum
(Levl.) raipaics which has been shown to effectively terminate AF and
supraventricular tachycardia in patients and animal models by
blocking multi-ion channels, but its effects on cellular electro phar-
macological activities of sodium channels are largely unknown in
atrial myocytes.
METHODS Primary atrial myocytes were isolated and cultured from
neonatal Sprague-Dawley rats (born 1-2 days). A single-pipette whole-
cell patch-clamp was used to investigate the acute effect of acehyti-
sine on sodium channels, and RT-PCR and western blot were used to
quantify a and b-subunits mRNA and protein expression implied
chronic effect on sodium channels.
RESULTS Atrial myocytes were cultured and plated into coverlips at
1104/cm2. 48h later, single cell was ruptured and INa was recorded in
absence and presence of acehytisine. It inhibited INa in a positive rate-
dependent and concentration-dependent manner, with IC50 value of
31.675.47mmol/L. 50mmol/L acehytisine signiﬁcantly shifted inacti-
vation curves toward left and shifted activation curves to right, but
did not modify the recovery kinetics from inactivation of sodium
channels. In addition, incubation with 100mmol/L acehytisine for
3-24h caused signiﬁcant decreases of a and b-subunits mRNA in time-
dependent manner (SCN5A decreased by 72.2418.21%, SCN1B
decreased by 52.8119.77%, SCN3B decreased by 83.4235.16% at 24h,
p <0.01 vs. untreated cells). Meanwhile, the quaniﬁcation of protein
levels was consistent with alteration of mRNA expression.
CONCLUSIONS These ﬁndings indicate that acehytisine inhibits sodium
channels by two modes, 1) inhibiting INa by binding to sodium channels
and 2) downregulating a and b-subunits at mRNA and protein levels,
which provides experimental evidence for anti-arrhythmia by acehytisine.GW26-e2401
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OBJECTIVES The deregulation of microRNAs (miRNAs), a class of
short and small non-coding RNAs, has been shown to be involved in a
wide range of cellular processes and cardiovascular pathologies. The
Apelin/APJ system has been implicated in the pathophysiology effects
in cardiovascular system, which is a necessary process in the initiation
and development of various cardiovascular diseases inclusive of
hypertension. We hypothesized that Apelin is a negative regulator
of hypertension-mediated pathological effects in spontaneously
hypertensive rats (SHR) model.
METHODS The 3-month-old male SHR and Wistar-Kyoto (WKY) rats
were obtained from Slac Laboratory Animal Co. Ltd. in China. Rats
received daily administration of Apelin or saline for 4 weeks. Systolic
blood pressure (SBP) of rat was measured by the tail-cuff method.
Vascular morphological analysis was processed using the computerimage analysis software for the quantiﬁcation of the media thickness
(MT), lumen diameter (LD), and the ratio of MT to LD, markers of
vascular hypertrophy and remodeling.
RESULTS In the SHR model, the aortic expression of miR-122-5p and
let-7b-3p were upregulated, while miR-1-3p, miR-376b-3p and miR-
298-5p were downregulated and negative correlated with SBP levels.
Compared with WKY rats, the MT and the MT/LD ratio of the thoracic
aorta were signiﬁcantly enhanced in SHR [MT: (127.24.5 um)
vs.(81.83.9 um); MT/LD ratio:(7.31.1) vs.(4.81.0); P<0.01, respec-
tively]. These changes were linked with the reduction of Apelin
expression and increased levels of ANF, and phosphorylated ERK1/2
as well as severe ultrastructural damage of the thoracic aorta. These
effects were signiﬁcantly blunted by Apelin treatment, in association
with a lowering of phosphorylated ERK1/2 levels and improvement of
ultrastructural injury. However, there were no changes in aortic
expression of APJ receptor among groups.
CONCLUSIONS There are abnormal levels of miRNAs and Apelin in
hypertensive status. In addition, Apelin is an important negative
regulator of the hypertension-induced pathological hypertrophy and
aortic remodeling and attenuates aortic ultrastructural injury in hy-
pertensive rats. These observations indicate that various miRNAs and
Apelin signaling in vasculature may be linked with hypertension and
provide novel pharmacologic implications for the prevention and
treatment of hypertension.
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OBJECTIVES Reduced expression of Sarcoplasmic reticulum calcium-
transporting ATPase isoform 2a (SERCA2a) has been shown to play a
signiﬁcant role in the cardiac dysfunction of obese animal models. It
was reported recently that SUMOylation enhances the stability and
activity of SERCA2a. We hypothesized that SERCA2a-SUMOylation
might be involved in obesity-mediated reduction of SERCA2a.
METHODS Trimetazidine (TMZ), the drug that inhibits fatty acid
oxidation, was used in diet-induced obesity (DIO) rats and palmitic
acid (PA)-treated cardiomyocytes. The intensity of SERCA2a-SUMOy-
lation and proteins involved in SERCA2a-SUMOylation were investi-
gated in vivo and in vitro.
RESULTS DIO rats presented cardiac dysfunction, which was allevi-
ated by TMZ treatment. Reductions of SERCA2a protein and the
intensity of SERCA2a-SUMOylation were observed in DIO rats and
PA-treated cardiomyocytes. These reductions were partially restored
by TMZ. However, TMZ itself did not alter the intensity of SERCA2a-
SUMOylation in control cardiomyocytes. The variations of protein and
mRNA levels of Ubc9 are in accordance with the intensity of SERCA2a-
SUMOylation. Whereas the other proteins involved in SERCA2a-
SUMOylation were not changed by DIO and PA.
CONCLUSIONS TMZ alleviates the DIO-induced and PA-induced
reductions of SERCA2a-SUMOylation. Ubc9 is involved in the reductions.
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Assessment of osteopontin, osteoprotegerin and activated monocytes/
macrophages on hypertensive patients with vascular calciﬁcation
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OBJECTIVES Vascular calciﬁcation (VC) is a highly regulated process in
which inﬂammatory cells inﬁltration and the factors controlling bone
mineralization are involved. This study aims to examine whether
osteopontin (OPN) and osteoprotegerin (OPG) exert effects in hyper-
tensive subjects with VC by regulating monocyte/macrophage activation.
METHODS We recruited 70 hypertensive subjects with or without
VC by artery electronic calculator tomography, peripheral blood
monocytes (CD14þ) and primary cultured macrophages were detected
